# A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum

> **NCT03512873** · EARLY_PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 56 (estimated)

## Conditions studied

- Scleredema Adultorum

## Interventions

- **DRUG:** Tranilast

## Key facts

- **NCT ID:** NCT03512873
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-12
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03512873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03512873, "A Clinical Study of Tranilast in the Treatment of Scleredema Diabeticorum". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT03512873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*